Interest in the continuous development of new treatments for depressive disorders is due to, among other things, that depressive disorders are still very widespread and debilitating diseases with major biopsychosocioeconomical consequences. The disease almost always requires a long attention and appropriate treatment, as it is a chronic, recurrent and relapsing disorder that results in many cases, long-term hospitalization or disability.